0001567619-21-008236.txt : 20210416
0001567619-21-008236.hdr.sgml : 20210416
20210416171310
ACCESSION NUMBER: 0001567619-21-008236
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210308
FILED AS OF DATE: 20210416
DATE AS OF CHANGE: 20210416
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Yelensky Roman
CENTRAL INDEX KEY: 0001754293
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38663
FILM NUMBER: 21832349
MAIL ADDRESS:
STREET 1: C/O GRITSTONE ONCOLOGY, INC.
STREET 2: 5858 HORTON STREET, SUITE 210
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Gritstone Oncology, Inc.
CENTRAL INDEX KEY: 0001656634
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5959 HORTON STREET, SUITE 300
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
BUSINESS PHONE: (510) 871-6100
MAIL ADDRESS:
STREET 1: 5959 HORTON STREET, SUITE 300
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
4
1
doc1.xml
FORM 4
X0306
4
2021-03-08
0
0001656634
Gritstone Oncology, Inc.
GRTS
0001754293
Yelensky Roman
C/O GRITSTONE ONCOLOGY, INC.
5959 HORTON STREET, SUITE 300
EMERYVILLE
CA
94608
0
1
0
0
See Remarks
Common Stock
2021-03-08
4
M
0
50724
0.759
A
183948
D
Stock Option (Right to Buy)
0.759
2021-03-08
4
M
0
50724
0
D
2027-02-07
Common Stock
50724
0
D
Fully exercisable.
Executive Vice President and Chief Technology Officer
/s/ Rahsaan Thompson, Attorney-in-Fact for Roman Yelensky
2021-04-16